Log In Sign up
The largest database of trusted experimental protocols

Anti h 2kb bound to siinfekl apc

Manufactured by BioLegend
Visit Supplier

Anti-H-2Kb bound to SIINFEKL-APC is a lab equipment product that binds to the MHC class I complex (H-2Kb) presenting the SIINFEKL peptide. It is conjugated to the fluorescent dye APC, allowing for detection and analysis.

Automatically generated - may contain errors

Lab products found in correlation

Anti cd8 pe cy7, by BioLegend (2 mentions) Anti gr 1 fitc, by BioLegend (2 mentions) Anti pd l1 pe, by BioLegend (2 mentions) Anti b220 apc cy7, by BioLegend (2 mentions) Anti f4 80 pecy7, by BioLegend (2 mentions) Pe anti rabbit igg, by BioLegend (2 mentions) Anti cd16 cd32, by BioLegend (2 mentions) Anti cd45.2 apc, by BioLegend (2 mentions) Anti cd11b pacif blue, by BioLegend (2 mentions) Anti cd45.2 apccy7, by BioLegend (2 mentions) Anti mhcii bv605, by BioLegend (2 mentions) Anti cd11c fitc, by BioLegend (2 mentions) Lsr 2 flow cytometer, by BD (2 mentions) Anti cd86 pe, by BioLegend (2 mentions)

Close spelling variants of this product

APC anti-mouse H-2Kb bound to SIINFEKL antibody H-2Kb bound to SIINFEKL H-2Kb SIINFEKL

2 protocols using anti h 2kb bound to siinfekl apc

1

Multiparameter Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies were purchased from Biolegend. The following primary antibodies were used: anti-CD16/CD32 (Biolegend, Cat#: 101301, clone: 93), anti-CD8-PE-cy7 (Biolegend, Cat#: 100721, clone: 53-6.7), anti-CD11c-FITC (Biolegend, Cat#: 117305, clone: N418) and anti-CD11b-Pacif blue (Biolegend, Cat#: 101223, clone: M1/70), anti-B220-APC-cy7 (Biolegend, Cat#: 103223, clone: RA3-6B2), anti-CD86-PE (Biolegend, Cat#: 105007, clone: GL-1), anti- H-2Kb bound to SIINFEKL-APC (Biolegend, Cat#:141605, clone:25-D1.16), anti-CD45.2-APC (Biolegend, Cat#:109814, clone:104), anti-CD45.2-APCcy7 (Biolegend, Cat#:109823, clone:104), anti-PD-L1-PE (Biolegend, Cat#:124307, clone:10F.9G2), isotype control-PE (Biolegend, Cat#:400607, clone:RTK4530), anti-F4/80-PE/cy7 (Biolegend, Cat#:123113, clone:BM8), anti-Gr-1-FITC (Biolegend, Cat#:108419, clone:RB608C5), anti-MHCII-BV605 (Biolegend, Cat#:107639, clone:M5/114.15.2), anti-rabbit IgG-PE (Biolegend, Cat#:406421, clone:poly4064). Flow data were acquired on a BD™ LSR II flow cytometer and analyzed using Flowjo software.
Luo M., Wang H., Wang Z., Cai H., Lu Z., Li Y., Du M., Huang G., Wang C., Chen X., Porembka M.R., Lea J., Frankel A.E., Fu Y.X., Chen Z.J, & Gao J. (2017). A STING-Activating Nanovaccine for Cancer Immunotherapy. Nature nanotechnology, 12(7), 648-654.
+ Open protocol
+ Expand
2

Multiparameter Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies were purchased from Biolegend. The following primary antibodies were used: anti-CD16/CD32 (Biolegend, Cat#: 101301, clone: 93), anti-CD8-PE-cy7 (Biolegend, Cat#: 100721, clone: 53-6.7), anti-CD11c-FITC (Biolegend, Cat#: 117305, clone: N418) and anti-CD11b-Pacif blue (Biolegend, Cat#: 101223, clone: M1/70), anti-B220-APC-cy7 (Biolegend, Cat#: 103223, clone: RA3-6B2), anti-CD86-PE (Biolegend, Cat#: 105007, clone: GL-1), anti- H-2Kb bound to SIINFEKL-APC (Biolegend, Cat#:141605, clone:25-D1.16), anti-CD45.2-APC (Biolegend, Cat#:109814, clone:104), anti-CD45.2-APCcy7 (Biolegend, Cat#:109823, clone:104), anti-PD-L1-PE (Biolegend, Cat#:124307, clone:10F.9G2), isotype control-PE (Biolegend, Cat#:400607, clone:RTK4530), anti-F4/80-PE/cy7 (Biolegend, Cat#:123113, clone:BM8), anti-Gr-1-FITC (Biolegend, Cat#:108419, clone:RB608C5), anti-MHCII-BV605 (Biolegend, Cat#:107639, clone:M5/114.15.2), anti-rabbit IgG-PE (Biolegend, Cat#:406421, clone:poly4064). Flow data were acquired on a BD™ LSR II flow cytometer and analyzed using Flowjo software.
Luo M., Wang H., Wang Z., Cai H., Lu Z., Li Y., Du M., Huang G., Wang C., Chen X., Porembka M.R., Lea J., Frankel A.E., Fu Y.X., Chen Z.J, & Gao J. (2017). A STING-Activating Nanovaccine for Cancer Immunotherapy. Nature nanotechnology, 12(7), 648-654.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!